| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Fulgent Genetics (NASDAQ:FLGT) is gearing up to announce its quarterly earnings on Friday, 2025-11-07. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Fulgent Genetics will report an earnings per share (EPS) of $-0.36.
Anticipation surrounds Fulgent Genetics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
The company's EPS beat by $0.40 in the last quarter, leading to a 0.0% drop in the share price on the following day.
Here's a look at Fulgent Genetics's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.18 | -0.12 | -0.15 |
| EPS Actual | 0.07 | 0.04 | 0.04 | 0.31 |
| Price Change % | 8.00 | 19.00 | -2.00 | -12.00 |
Shares of Fulgent Genetics were trading at $22.78 as of November 05. Over the last 52-week period, shares are up 17.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Fulgent Genetics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: FLGT
